A CRITICAL ANALYSIS OF PATENT LAW FRAMEWORKS FOR BALANCING PRIVATE INNOVATION AND PUBLIC INTEREST IN GLOBAL HEALTH
- Authors
-
-
Abdurakhimova Solikha
Civil Law and Private International Law Department World Economy and Diplomacy University, Tashkent, Uzbekistan
Author
-
- Keywords:
- Compulsory licensing, Public interest, Private innovation incentives, Evergreening, Generic drugs, High drug pricing, United States patent law, European Union IP framework, India Patents Act, COVID-19 vaccine patents, Patent pools, Medicines Patent Pool (MPP), Public-private partnerships (PPPs), Differential pricing, Technology transfer, Bayh-Dole Act, Supplementary protection certificates (SPCs), Patent thickets
- Abstract
-
With regard to global health, this article critically assesses the balance between private innovation incentives and public interests that are contemplated by current patent law frameworks in the United States, Europe and India. To encourage pharmaceutical research and development, patent systems need to be in place but too often result in high drug prices and in the absence of essential medicines in relatively poor countries. Using an economic notion, we explore the economic reason of giving patent protections, how to increase the accessibility during a global health crisis – e.g. the pandemic for COVID-19 – and how legal mechanisms such as compulsory licensing, patent pools and anti-evergreening provisions can increase the access. Through its Patents Act and judicial decisions, the article reveals that India’s approach is more pro public when compared to US and EU. The final part of the article states that current patent regimes are favorable to private interests and that change along the path towards equitable access, particularly during a health emergency, is possible through stronger international cooperation as well as through the strategic adoption of legal reforms.
- References
-
1.Joseph A DiMasi, Henry G Grabowski and Ronald W Hansen, ‘Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs’ (2016) 47 Journal of Health Economics 20, 23.
2.Peter Roderick and Allyson M Pollock, ‘Compulsory Licensing: A Critical Tool in the COVID-19 Pandemic’ (2021) 397 The Lancet 378, 379.
3.Amy Kapczynski, ‘The Public Interest in Intellectual Property Law’ (2021) 73 Stanford Law Review 1231, 1245.
4.Thomas Pogge, ‘Human Rights and Global Health: A Research Program’ (2005) 36 Metaphilosophy 182, 195.
- Downloads
- Published
- 2026-04-06
- Issue
- Vol. 2 No. 4 (2026)
- Section
- Articles
- License
-

This work is licensed under a Creative Commons Attribution 4.0 International License.








